M. Starovoitova

Successful experience with divozilimab therapy for systemic sclerosis

Systemic sclerosis (SSc) is a severe rheumatic disease characterized by high mortality and reduced quality of life. Over the past 10–15 years, the treatment paradigm for SSc has changed dramatically owing to a better understanding of its pathogenesis, the accumulation of evidence supporting the efficacy of immunosuppre...